XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Interim Consolidated Statements of Shareholder's Equity (Unaudited) - CAD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in capital
Share-based Reserve
Additional Paid-in capital
Warrants
Additional Paid-in capital
Ownership Changes
Additional Paid-in capital
Redeemable Noncontrolling Interest
Accumulated Other Comprehensive Income (Loss)
Deficit
Noncontrolling Interests
Beginning balance at Mar. 31, 2023 $ 760,022 $ 7,938,571 $ 498,150 $ 2,581,788 $ (521,961) $ (51,492) $ (13,860) $ (9,672,761) $ 1,587
Other issuances of common shares and warrants 118,803 120,470         (1,667)    
Share-based compensation 3,716   3,716            
Issuance and vesting of restricted share units and performance share units   6,240 (6,240)            
Changes in redeemable noncontrolling interest           (3,740)     3,740
Redemption of redeemable noncontrolling interest (193)       (181)       (12)
Comprehensive income (loss) (34,843)           7,018 (38,121) (3,740)
Ending balance at Jun. 30, 2023 847,505 8,065,281 495,626 2,581,788 (522,142) (55,232) (8,509) (9,710,882) 1,575
Private Placement, net of issuance costs 31,633 12,836 9,820 8,977          
Other issuances of common shares and warrants 145,200 132,553 (80)       12,727    
Exercise of Previous Equity Incentive Plan stock options   165 (165)            
Share-based compensation 2,718   2,718            
Issuance and vesting of restricted share units and performance share units   561 (561)            
Changes in redeemable noncontrolling interest           (14,786)     14,786
Ownership changes relating to noncontrolling interests, net 68,582         $ 70,018     (1,436)
Redemption of redeemable noncontrolling interest 7,643 8,450     (807)        
Comprehensive income (loss) (353,817)           (29,017) (310,014) (14,786)
Ending balance at Sep. 30, 2023 749,464 8,219,846 507,358 2,590,765 (522,949)   (24,799) (10,020,896) 139
Other issuances of common shares and warrants (447) (447)              
Share-based compensation 3,693   3,693            
Issuance and vesting of restricted share units and performance share units   348 (348)            
Comprehensive income (loss) (208,047)           8,750 (216,797)  
Ending balance at Dec. 31, 2023 544,663 8,219,747 510,703 2,590,765 (522,949)   (16,049) (10,237,693) 139
Beginning balance at Mar. 31, 2024 500,507 8,244,301 514,578 2,610,519 (522,949)   (16,051) (10,330,030) 139
Common shares issued from ATM Program 46,291 46,291              
Other issuances of common shares warrants and share issue costs (3,189) (3,189)              
Exercise of warrants 7,563 10,265   (2,702)          
Share-based compensation 4,151   4,151            
Issuance and vesting of restricted share units and performance share units   2,596 (2,596)            
Extinguishment of promissory note and issuance of exchangeable shares 74,098 81,220 8,005       (15,127)    
Canopy USA Transaction 22,711 12,452         10,398   (139)
Supreme debt settlement 8,697     8,697          
Comprehensive income (loss) (127,906)           (768) (127,138)  
Ending balance at Jun. 30, 2024 532,923 8,393,936 524,138 2,616,514 (522,949)   (21,548) (10,457,168)  
Beginning balance at Mar. 31, 2024 500,507 8,244,301 514,578 2,610,519 (522,949)   (16,051) (10,330,030) $ 139
Supreme debt settlement 13,525                
Disposal and liquidation of consolidated entities             18,593    
Ending balance at Dec. 31, 2024 591,475 8,670,494 532,149 2,628,137 (522,949)   (8,999) (10,707,357)  
Beginning balance at Jun. 30, 2024 532,923 8,393,936 524,138 2,616,514 (522,949)   (21,548) (10,457,168)  
Common shares issued from ATM Program 92,185 92,185              
Other issuances of common shares warrants and share issue costs (1,522) (1,522)              
Exercise of Previous Equity Incentive Plan stock options 112 238 (126)            
Exercise of warrants 891 1,207   (316)          
Share-based compensation 5,221   5,221            
Issuance and vesting of restricted share units and performance share units   1,991 (1,991)            
Supreme debt settlement 2,635 2,635              
Comprehensive income (loss) (122,777)           5,516 (128,293)  
Ending balance at Sep. 30, 2024 509,668 8,490,670 527,242 2,616,198 (522,949)   (16,032) (10,585,461)  
Common shares issued from ATM Program 117,513 117,513              
Other issuances of common shares warrants and share issue costs 73,998 62,059   11,939          
Exercise of Previous Equity Incentive Plan stock options   70 (70)            
Share-based compensation 5,159   5,159            
Issuance and vesting of restricted share units and performance share units   182 (182)            
Disposal and liquidation of consolidated entities 8,195           8,195    
Comprehensive income (loss) (123,058)           (1,162) (121,896)  
Ending balance at Dec. 31, 2024 $ 591,475 $ 8,670,494 $ 532,149 $ 2,628,137 $ (522,949)   $ (8,999) $ (10,707,357)